Sequential dose intensive chemotherapy with cyclophosphamide and carboplatin (CC) with peripheral blood progenitor cell (PBPC) support in metastatic breast cancer patients.

被引：0
|
作者：
Bauernhofer, T [1 ]
Schmid, M [1 ]
Stoeger, H [1 ]
Kasparek, AK [1 ]
Ploner, F [1 ]
Kuss, I [1 ]
Gilli, R [1 ]
Lanzer, H [1 ]
Samonigg, H [1 ]
机构：
[1] Karl Franzens Univ Graz, Dept Internal Med, Div Oncol, Dept Transfus Med, Graz, Austria
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
114
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [1] High-dose chemotherapy (HDC) with autologous peripheral blood progenitor cell (PBPC) support in patients with metastatic breast cancer
    Constenla, M
    Lorenzo, I
    Carrete, N
    Rey, C
    Campos, B
    Arroyo, FR
    Ozores, R
    Castro, A
    Solla, E
    Villascusa, R
    BONE MARROW TRANSPLANTATION, 1999, 23 : S40 - S40
  • [2] Sequential high-dose chemotherapy with autologous peripheral blood progenitor cell transplantation for breast cancer patients.
    Corsini, C
    Agazzi, A
    Paolucci, M
    Tealdo, F
    Peccatori, F
    Goldhirsch, A
    Martinelli, G
    BLOOD, 1997, 90 (10) : 4552 - 4552
  • [3] High dose chemotherapy with peripheral blood progenitor support in metastatic breast cancer
    Nitz, U
    Mohrmann, S
    Bender, HG
    GYNAKOLOGE, 1999, 32 (08): : 632 - 637
  • [4] Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
    LT Vahdat
    C Balmaceda
    K Papadopoulos
    D Frederick
    D Donovan
    E Sharpe
    E Kaufman
    D Savage
    A Tiersten
    G Nichols
    J Haythe
    A Troxel
    K Antman
    CS Hesdorffer
    Bone Marrow Transplantation, 2002, 30 : 149 - 155
  • [5] Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
    Vahdat, LT
    Balmaceda, C
    Papadopoulos, K
    Frederick, D
    Donovan, D
    Sharpe, E
    Kaufman, E
    Savage, D
    Tiersten, A
    Nichols, G
    Haythe, J
    Troxel, A
    Antman, K
    Hesdorffer, CS
    BONE MARROW TRANSPLANTATION, 2002, 30 (03) : 149 - 155
  • [6] Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
    Vahdat, LT
    Papadopoulos, K
    Balmaceda, C
    McGovern, T
    Dunleavy, J
    Kaufman, E
    Fung, B
    Garrett, T
    Savage, D
    Tiersten, A
    Ayello, J
    Bagiella, E
    Heitjan, D
    Antman, K
    Hesdorffer, C
    CLINICAL CANCER RESEARCH, 1998, 4 (07) : 1689 - 1695
  • [7] Peripheral blood progenitor cells (PBPC) mobilization with filgrastim in breast cancer patients.
    Navalon, M
    Cruz, JJ
    San Miguel, JF
    Corral, M
    Gómez, A
    Sánchez, P
    Martin, G
    Fonseca, E
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S98 - S98
  • [8] High-dose chemotherapy (IQ) with autologous peripheral blood progenitor cell (PBPC) support in patients with advanced breast cancer: Early results
    Constenla, M
    Garcia-Arroyo, FR
    Ozores, R
    Lorenzo, L
    Rey, C
    Castro, A
    Solla, E
    Villascusa, R
    BONE MARROW TRANSPLANTATION, 1998, 21 : S57 - S57
  • [9] High-dose sequential chemotherapy (HDSC) with peripheral blood progenitor cells (PBPC) support for high-risk breast cancer (BC)
    Sabbatini, R.
    Da Prada, G. A.
    Frassineti, G. L.
    Aietta, M.
    Pedrazzoli, P.
    Maur, M.
    Zambelli, A.
    Giovannini, N.
    Siena, S.
    Ponchio, L.
    Conte, P. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] The emergence of peripheral blood progenitor cells to support intensive chemotherapy for patients with breast cancer
    Demetri, GD
    PHARMACOTHERAPY, 1996, 16 (03): : S94 - S100
12345